HADV (Health Advance) Notes Receivable: $0.00 Mil (As of Sep. 2017)


What is Health Advance Notes Receivable?

Health Advance HADV Notes Receivable is $0.00 Mil as of Sep. 2017.

Health Advance's Notes Receivable for the quarter that ended in Sep. 2017 was $0.00 Mil.

Health Advance Notes Receivable Historical Data

* Premium members only.

The historical data trend for Health Advance's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Advance Notes Receivable Chart

Health Advance Annual Data
Trend Jul11 Jul12 Jul13 Jul14 Jul15
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Health Advance Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Sep17
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Health Advance Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Health Advance (HADV) has a Notes Receivable of $0.00 Mil as of Sep. 2017. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Health Advance and its competitors.
Is Health Advance's Notes Receivable too high?
Health Advance's current Notes Receivable is $0.00 Mil.
How does Health Advance's Notes Receivable compare to MYDP and HEWA?
Health Advance's Notes Receivable of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Health Advance and its competitors. Health Advance's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Advance stock overvalued right now?
Health Advance (HADV) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Health Advance (HADV), the current Notes Receivable is $0.00 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Advance Business Description

Address 9131 Keele Street, Suite A4, Vaughan, ON, CAN, L4K 0G7
Health Advance Inc is engaged in the retail domain. The Company is focused on products that are oriented to health and wellness. The first example of this is a proprietary CBD-infused wine beverage. The company is in the analysis stage for Immune boosting nutraceuticals, and human wellness products.